Sign in
4

Changes in Ownership

Amphastar Pharmaceuticals, Inc. Filed Acc 0001104659-18-068861

Director sold 29,278 shares at $20.39 ($596,949)

  • Director acquired 29,278 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

ZASLOFF MICHAEL A · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2018-11-14 Exercise or conversion : show line 1 in the form +29,278 $14.66 $429,215 59,123 D
2018-11-14 Sale : show line 2 in the form −29,278 $20.39 $596,949 29,845 D
Open-market sales · 29,278 sh · avg $20.39 · $596,949

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2018-11-14 Exercise or conversion : show line 3 in the form Stock Option (right to buy) −29,278 0 D
Loading xslF345X03/a4.xml…